ACUTE-PHASE REACTANTS AND SEVERITY OF HOMOZYGOUS SICKLE-CELL DISEASE

被引:58
作者
HEDO, CC [1 ]
AKENOVA, YA [1 ]
OKPALA, IE [1 ]
DUROJAIYE, AO [1 ]
SALIMONU, LS [1 ]
机构
[1] UNIV COLL HOSP IBADAN, DEPT CHEM PATHOL, CTR IMMUNOL RES & TRAINING, IBADAN, NIGERIA
关键词
ACUTE-PHASE PROTEINS; DISEASE SEVERITY; SICKLE CELL ANEMIA;
D O I
10.1111/j.1365-2796.1993.tb01000.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serum concentrations of seven acute-phase reactants: albumin, transferrin (Tf), alpha-1-antitrypsin (AIAT), caeruloplasmin (Cp), alpha2-macroglobulin (alpha2-MG), haptoglobin (hp) and C-reactive protein (CRP) were determined in 73 subjects with varying severities of homozygous sickle cell (HbSS) disease. Fifty healthy subjects of comparable sex, age and socio-economic class distributions as the HbSS subjects served as controls. Albumin and alpha2-MG were comparable in all the subject groups. Tf and hp levels were significantly reduced in the HbSS groups relative to the control group. Conversely, AIAT. CRP and CP were significantly elevated. However only Tf and CRP manifested significant correlations with any of the indices of disease severity employed. Transferrin and CRP are suggested as plasma proteins worthy of further evaluation as indicators of severity in homozygous sickle cell disease.
引用
收藏
页码:467 / 470
页数:4
相关论文
共 19 条
[1]   ALPHA-1-ANTITRYPSIN IS AN EFFECTOR OF IMMUNOLOGICAL STASIS [J].
ARORA, PK ;
MILLER, HC ;
ARONSON, LD .
NATURE, 1978, 274 (5671) :589-590
[2]  
BROCK JH, 1981, IMMUNOLOGY, V43, P387
[3]  
Dacie JV, 1984, PRACTICAL HAEMATOLOG, P179
[4]  
Doumas B.T., 1972, STAND METH CLIN CHEM, V7, P175
[5]   THE FEATURES OF SICKLE-CELL DISEASE IN SAUDI CHILDREN [J].
ELHAZMI, MAF ;
BAHAKIM, HM ;
ALSWAILEM, AM ;
WARSY, AS .
JOURNAL OF TROPICAL PEDIATRICS, 1990, 36 (04) :148-155
[6]  
EZEOKE A C J, 1986, Nigerian Journal of Paediatrics, V13, P13
[7]  
FIEDEL BA, 1986, J IMMUNOL, V136, P2551
[8]  
FINKELSTEIN RA, 1983, REV INFECT DIS, V5, pS759
[9]  
HOKAMA Y, 1973, J RETICULOENDOTH SOC, V13, P111
[10]  
KUSHNER I, 1988, METHOD ENZYMOL, V163, P373